
Paul J. Killos
Examiner (ID: 930)
| Most Active Art Unit | 1206 |
| Art Unit(s) | 1204, 1206, 1625, 1621, 1623 |
| Total Applications | 2978 |
| Issued Applications | 2595 |
| Pending Applications | 134 |
| Abandoned Applications | 247 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 3780752
[patent_doc_number] => 05821069
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-10-13
[patent_title] => 'Method for determining tyrosine kinase in a sample'
[patent_app_type] => 1
[patent_app_number] => 8/805445
[patent_app_country] => US
[patent_app_date] => 1997-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 37
[patent_no_of_words] => 10764
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/821/05821069.pdf
[firstpage_image] =>[orig_patent_app_number] => 805445
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/805445 | Method for determining tyrosine kinase in a sample | Feb 24, 1997 | Issued |
| 08/804561 | SECRETED PROTEINS AND POLYNUCLEOTIDES ENCODING THEM | Feb 23, 1997 | Pending |
Array
(
[id] => 4236587
[patent_doc_number] => 06117980
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-09-12
[patent_title] => 'Humanized anti-IL-8 monoclonal antibodies'
[patent_app_type] => 1
[patent_app_number] => 8/804444
[patent_app_country] => US
[patent_app_date] => 1997-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 71
[patent_figures_cnt] => 82
[patent_no_of_words] => 56422
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/117/06117980.pdf
[firstpage_image] =>[orig_patent_app_number] => 804444
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/804444 | Humanized anti-IL-8 monoclonal antibodies | Feb 20, 1997 | Issued |
Array
(
[id] => 4316577
[patent_doc_number] => 06242575
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-05
[patent_title] => 'Antibodies for detecting p27 protein'
[patent_app_type] => 1
[patent_app_number] => 8/822936
[patent_app_country] => US
[patent_app_date] => 1997-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 41
[patent_no_of_words] => 25648
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/242/06242575.pdf
[firstpage_image] =>[orig_patent_app_number] => 822936
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/822936 | Antibodies for detecting p27 protein | Feb 20, 1997 | Issued |
Array
(
[id] => 4045107
[patent_doc_number] => 05912224
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-06-15
[patent_title] => 'Methods and compositions for enhancing cellular response to TGF-.beta. ligands'
[patent_app_type] => 1
[patent_app_number] => 8/803899
[patent_app_country] => US
[patent_app_date] => 1997-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 42
[patent_no_of_words] => 25199
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/912/05912224.pdf
[firstpage_image] =>[orig_patent_app_number] => 803899
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/803899 | Methods and compositions for enhancing cellular response to TGF-.beta. ligands | Feb 20, 1997 | Issued |
Array
(
[id] => 4179450
[patent_doc_number] => 06037332
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-14
[patent_title] => 'Method of urinary bladder instillation'
[patent_app_type] => 1
[patent_app_number] => 8/803310
[patent_app_country] => US
[patent_app_date] => 1997-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 1777
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/037/06037332.pdf
[firstpage_image] =>[orig_patent_app_number] => 803310
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/803310 | Method of urinary bladder instillation | Feb 19, 1997 | Issued |
Array
(
[id] => 4011280
[patent_doc_number] => 05889170
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-30
[patent_title] => 'Human integral membrane protein'
[patent_app_type] => 1
[patent_app_number] => 8/791338
[patent_app_country] => US
[patent_app_date] => 1997-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 20171
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/889/05889170.pdf
[firstpage_image] =>[orig_patent_app_number] => 791338
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/791338 | Human integral membrane protein | Jan 30, 1997 | Issued |
Array
(
[id] => 3988524
[patent_doc_number] => 05891618
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-04-06
[patent_title] => 'Method for quantifying LBP in body fluids'
[patent_app_type] => 1
[patent_app_number] => 8/779400
[patent_app_country] => US
[patent_app_date] => 1997-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 5618
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/891/05891618.pdf
[firstpage_image] =>[orig_patent_app_number] => 779400
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/779400 | Method for quantifying LBP in body fluids | Jan 6, 1997 | Issued |
| 08/778002 | ADENOVIRUS-CANCER ANTIGEN VECTOR | Dec 30, 1996 | Abandoned |
Array
(
[id] => 3935184
[patent_doc_number] => 05981198
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-09
[patent_title] => 'Preimplantation factor'
[patent_app_type] => 1
[patent_app_number] => 8/777911
[patent_app_country] => US
[patent_app_date] => 1996-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 3611
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/981/05981198.pdf
[firstpage_image] =>[orig_patent_app_number] => 777911
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/777911 | Preimplantation factor | Dec 22, 1996 | Issued |
Array
(
[id] => 4114968
[patent_doc_number] => 06046158
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-04
[patent_title] => 'Unique dendritic cell-associated C-type lectins, dectin-1 and dectin-2; compositions and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/772440
[patent_app_country] => US
[patent_app_date] => 1996-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 17
[patent_no_of_words] => 61825
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/046/06046158.pdf
[firstpage_image] =>[orig_patent_app_number] => 772440
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/772440 | Unique dendritic cell-associated C-type lectins, dectin-1 and dectin-2; compositions and uses thereof | Dec 19, 1996 | Issued |
| 08/757205 | HUMANIZED ANTI-CD11A ANTIBODIES | Nov 26, 1996 | Abandoned |
Array
(
[id] => 4027910
[patent_doc_number] => 05994088
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-30
[patent_title] => 'Methods and reagents for preparing and using immunological agents specific for P-glycoprotein'
[patent_app_type] => 1
[patent_app_number] => 8/752447
[patent_app_country] => US
[patent_app_date] => 1996-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 16119
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/994/05994088.pdf
[firstpage_image] =>[orig_patent_app_number] => 752447
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/752447 | Methods and reagents for preparing and using immunological agents specific for P-glycoprotein | Nov 14, 1996 | Issued |
Array
(
[id] => 3757418
[patent_doc_number] => 05843677
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-01
[patent_title] => 'Method of assaying asialoglycoprotein receptor and assay reagent therefor'
[patent_app_type] => 1
[patent_app_number] => 8/722153
[patent_app_country] => US
[patent_app_date] => 1996-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 7741
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/843/05843677.pdf
[firstpage_image] =>[orig_patent_app_number] => 722153
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/722153 | Method of assaying asialoglycoprotein receptor and assay reagent therefor | Oct 17, 1996 | Issued |
Array
(
[id] => 4029388
[patent_doc_number] => 05855888
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-05
[patent_title] => 'Drug for the treatment of rheumatoid arthritis'
[patent_app_type] => 1
[patent_app_number] => 8/727406
[patent_app_country] => US
[patent_app_date] => 1996-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3147
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/855/05855888.pdf
[firstpage_image] =>[orig_patent_app_number] => 727406
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/727406 | Drug for the treatment of rheumatoid arthritis | Oct 16, 1996 | Issued |
Array
(
[id] => 3785389
[patent_doc_number] => 05736401
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-07
[patent_title] => 'Stabilized standards and calibrators containing rapamycin and tactrolimus bound to FK binding proteins'
[patent_app_type] => 1
[patent_app_number] => 8/723203
[patent_app_country] => US
[patent_app_date] => 1996-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 15
[patent_no_of_words] => 3051
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/736/05736401.pdf
[firstpage_image] =>[orig_patent_app_number] => 723203
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/723203 | Stabilized standards and calibrators containing rapamycin and tactrolimus bound to FK binding proteins | Sep 26, 1996 | Issued |
Array
(
[id] => 4148374
[patent_doc_number] => 06106834
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-22
[patent_title] => 'Use of anti-CD45 leukocyte antigen antibodies for immunomodulation'
[patent_app_type] => 1
[patent_app_number] => 8/715342
[patent_app_country] => US
[patent_app_date] => 1996-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 12792
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/106/06106834.pdf
[firstpage_image] =>[orig_patent_app_number] => 715342
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/715342 | Use of anti-CD45 leukocyte antigen antibodies for immunomodulation | Sep 17, 1996 | Issued |
Array
(
[id] => 4041495
[patent_doc_number] => 05874286
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-23
[patent_title] => 'Tumor proteins'
[patent_app_type] => 1
[patent_app_number] => 8/715204
[patent_app_country] => US
[patent_app_date] => 1996-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 12
[patent_no_of_words] => 16258
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/874/05874286.pdf
[firstpage_image] =>[orig_patent_app_number] => 715204
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/715204 | Tumor proteins | Sep 16, 1996 | Issued |
Array
(
[id] => 3753742
[patent_doc_number] => 05843440
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-01
[patent_title] => 'Cellular and serum protein anchors for modulating pharmacokinetics'
[patent_app_type] => 1
[patent_app_number] => 8/702127
[patent_app_country] => US
[patent_app_date] => 1996-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6584
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/843/05843440.pdf
[firstpage_image] =>[orig_patent_app_number] => 702127
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/702127 | Cellular and serum protein anchors for modulating pharmacokinetics | Aug 13, 1996 | Issued |
Array
(
[id] => 3858084
[patent_doc_number] => 05792648
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-11
[patent_title] => 'Human macrophage antigen'
[patent_app_type] => 1
[patent_app_number] => 8/690095
[patent_app_country] => US
[patent_app_date] => 1996-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16777
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/792/05792648.pdf
[firstpage_image] =>[orig_patent_app_number] => 690095
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/690095 | Human macrophage antigen | Jul 30, 1996 | Issued |